VolitionRX Limited (VNRX) Q1 2024 Earnings
VNRX·Reported May 13, 2024·After market close
VolitionRX Limited reported Q1 2024 revenue of $171.5K, missed analyst consensus of $390.0K by $218.5K. Diluted EPS came in at $-0.10, beat the $-0.11 consensus by $0.01.
Revenue
$171.5Kmissed by $218.5K
Consensus: $390.0KDiluted EPS
$-0.10beat by $0.01
Consensus: $-0.11
Financial Snapshot
Trailing eight quarters through Q1 2024
Q1 2024 Earnings FAQ
Common questions about VolitionRX Limited's Q1 2024 earnings report.
VolitionRX Limited (VNRX) reported Q1 2024 earnings on May 13, 2024 after market close.
VolitionRX Limited reported revenue of $171.5K and diluted EPS of $-0.10 for Q1 2024.
Revenue missed the consensus estimate of $390.0K by $218.5K. EPS beat the consensus estimate of $-0.11 by $0.01.
You can read the 10-Q periodic report (0001477932-24-002775) directly on SEC EDGAR. The filing index links above go to sec.gov.